Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations

Two sensitive, selective, economic, and validated spectrofluorimetric methods were developed for the determination of ebastine (EBS) in pharmaceutical preparations depending on reaction with its tertiary amino group. Method I involves condensation of the drug with mixed anhydrides (citric and acetic anhydrides) producing a product with intense fluorescence, which was measured at 496 nm after excitation at 388 nm

The role of diffusion-weighted MRI: In assessment of response to radiotherapy for prostate cancer

Objective: The objective of our study was to investigate the changes of apparent diffusion coefficient (ADC) values in prostate cancers before and after radiotherapy at 1.5 T using a phased-array coil. Materials and methods: Twenty-five patients with biopsy-proven prostate cancer who received radiotherapy underwent diffusion-weighted imaging (DWI) at 1.5 T and were included in the study. Biopsies in all patients were performed before the initial MRI examination (range, 15–30 days before MRI; mean, 21.1 days). All 25 patients underwent DWI (b values = 0 and 1000 s/mm2) before and 1–3 months after the completion of radiotherapy. The changes in ADC values were measured for cancers and benign tissues before and after therapy. Additionally, the changes in serum prostate-specific antigen (PSA) levels were evaluated before and after therapy. Results: The mean ADC value after therapy (1.418 × 10−3 mm2/s) was increased compared with the mean ADC value before therapy (0.756 × 10−3 mm2/s) (p  0.5). The median PSA level after therapy (1.39 ng/mL) was decreased compared with the median PSA level before therapy (27.20 ng/mL). Conclusion: With the use of a 1.5-T MR scanner, our preliminary results suggest that ADC values may be useful as a non-invasive imaging biomarker for monitoring therapeutic response of prostate cancer to radiotherapy

Role of multiphasic multi-detector computed tomography (MDCT) in the diagnosis and staging of solid neoplastic renal masses

Objectives: The aim of this study was to assess the role of multi-detector computed tomography (MDCT) in diagnosis and preoperative staging of solid renal masses. Patients and methods: During two years duration we prospectively evaluated 56 patients with solid renal lesions previously detected by US. All patients underwent multiphasic CT scanning for the kidneys and urinary tract following a preset scanning protocol that included unenhanced, corticomedullary phase (CMP), nephrograhic phase (NP) and excretory phase (EP) scanning. The images obtained in the excretory delayed phase were reconstructed in different planes to obtain 2D and 3D reformatted images providing volume rendering VR and maximum intensity projection (MIP) CTU images. Curved reformatting was sometimes used for the ureter. The numbers of lesions detected in all three phases were determined. Results of CT scan were compared with histopathology or constellation of clinical and imaging patient data. Results: A total of 61 masses were detected in 56 cases, 51 cases had unilateral masses (91%), 5 cases had bilateral masses (9%). The different pathologies encountered in the study were RCC 39 masses (64%), Wilm’s tumor 3 masses (4.9%), transitional cell carcinoma 3 masses (4.9%), angiomyolipoma 7 masses (11.5%), lymphoma 6 masses (9.8%), metastasis one mass (1.6%), angiomyolipoma associated with RCC two masses (3.3%). Lymph nodal metastasis, renal vein, IVC thrombosis and distant metastatic spread in different pathologies were assessed. The attenuation HU values calculated in the early CMP for all cases of RCC had a mean value of 80.5 HU (STD 45.7) while the mean values in NP and EP were 70.6 HU (STD 25.4) and 51.3 HU (STD 19.2) respectively. A pattern of enhancement was detected in all cases of RCC in the form of rapid wash out of contrast and decrease of attenuation (HU) by time throughout different phases. Significant difference between HU in CMP and EP in cases of RCC (P value = 0.0002) and difference between HU in NP and EP in cases of RCC (P value < 0.00001) were found. Conclusion: Multiphase multislice computed tomography combined with CT angiography and CT urography have a major role in solid renal neoplastic masses’ diagnosis, characterization and differentiating benign and malignant tumors